ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase II Study of Cetuximab Plus Irinotecan in Patients With EGFR-detectable Metastatic Colorectal Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00362102
Recruitment Status : Completed
First Posted : August 9, 2006
Last Update Posted : November 22, 2016
Sponsor:
Information provided by (Responsible Party):
Eli Lilly and Company